QLY Biotech Group Corp. reported earnings results for the full year ended August 31, 2022. For the full year, the company reported net loss was USD 0.014112 million compared to USD 0.029503 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -5.66% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 38.95L | |
+12.66% | 14TCr | |
-16.92% | 1.65TCr | |
+77.49% | 906.11Cr | |
+7.62% | 473.98Cr | |
-0.88% | 292.84Cr | |
-18.49% | 243.32Cr | |
0.00% | 241.72Cr | |
+22.34% | 233.6Cr | |
-1.99% | 183.37Cr |
- Stock Market
- Equities
- LQLY Stock
- News QLY Biotech Group Corp.
- QLY Biotech Group Corp. Reports Earnings Results for the Full Year Ended August 31, 2022